Comprehensive Clinical Research   Report issue

For profit Phase 2
Founded: Berlin NJ United States (1998)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2012
NCT01728753
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Comprehensive Clinical Research, Berlin, NJ 08009

Active Ingredients

Drugs in Phase 2 Trials (1)

favipiravir (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1